结直肠癌肝转移二期肝切除中促纤维增生生长模式与二期完成及生存改善相关
本研究回顾性分析67例计划行二期肝切除的结直肠癌肝转移患者,评估一期切除标本中肝转移灶的组织学生长模式与病理缓解、二期手术完成及生存的关系。结果显示促纤维增生生长模式在病理缓解良好者中更常见,且与二期手术完成及更长的总生存和无复发生存相关。
要点
- 促纤维增生生长模式与病理缓解良好显著相关(P<.001)。
- 促纤维增生生长模式与非促纤维增生模式相比,二期肝切除完成率更高(多因素P=.041)。
- 非促纤维增生生长模式是总生存较差的独立因素(HR=4.17,95%CI 1.79-9.74,P<.001)。
核心结论
- 促纤维增生生长模式可能作为早期识别可从二期肝切除完成中获益患者的形态学标志物。
研究设计与样本
- 回顾性研究,纳入67例计划行二期肝切除的结直肠癌肝转移患者,评估一期切除标本的生长模式与病理缓解。
主要发现
- 促纤维增生生长模式在病理缓解良好者中更常见(P<.001)。
- 单因素和多因素分析显示二期肝切除完成与促纤维增生生长模式相关(P=.017和P=.041)。
- 中位随访84个月(95%CI 53.4-未达到)。
- 单因素分析中,非促纤维增生生长模式患者总生存较差(HR=3.86,95%CI 2.11-7.07,P<.001),病理无缓解者总生存也较差(HR=2.14,95%CI 1.19-3.83,P=.009)。
- 多因素分析中,非促纤维增生生长模式是总生存较差的唯一相关因素(HR=4.17,95%CI 1.79-9.74,P<.001),并与无复发生存较差相关(HR=2.05,95%CI 1.13-3.70,P=.017)。
关键数值与推荐
- 病理缓解良好定义为:肿瘤退缩分级(TRG)1-3、改良TRG 1-3、Blazer 0和1。
临床怎么用
- 对于计划行二期肝切除的结直肠癌肝转移患者,可依据一期切除标本的生长模式辅助判断二期手术完成的可能性及预后。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Two-stage hepatectomy for bilobar colorectal cancer liver metastases is potentially curative for selected patients. Histological growth patterns of colorectal liver metastases (desmoplastic, replacement, and pushing) have prognostic value. Our aim was to evaluate their association with pathologic response to preoperative treatment, second-stage hepatectomy completion, and survival in patients treated with a curative-intent 2-stage hepatectomy. METHODS: In 67 patients planned for 2-stage hepatectomy, colorectal liver metastases resected from the first-stage hepatectomy were retrospectively evaluated for growth patterns and pathologic response according to Tumor Regression Grading, modified Tumor Regression Grading, and Blazer grading. Tumor Regression Grading 1 to 3, modified Tumor Regression Grading 1 to 3, and Blazer 0 and 1 defined good responders. RESULTS: Desmoplastic growth patterns (GP) were more frequent among good responders (P < .001). Second-stage hepatectomy completion was associated with desmoplastic growth patterns and pathologic response on univariate analysis and multivariable analyses (P = .017 and P = .041, respectively). Median follow-up was 84 months (95% confidence interval: 53.4 [not reached]). Nondesmoplastic GP patients and nonresponders had a poorer overall survival (hazard ratio = 3.86, 95% confidence interval: 2.11-7.07, P < .001 and hazard ratio = 2.14, 95% confidence interval: 1.19-3.83, P = .009, respectively) on univariate analysis. Nondesmoplastic growth pattern was the only factor associated with a poorer overall survival on multivariable analysis (hazard ratio = 4.17, 95% confidence interval: 1.79-9.74, P < .001). Nondesmoplastic GP was also associated with a poorer recurrence-free survival (hazard ratio = 2.05, 95% confidence interval: 1.13-3.70, P = .017). CONCLUSION: Desmoplastic GP could represent a useful morphological marker for early identification of patients who might benefit from 2-stage hepatectomy completion.
引用
- Khellaf L, Quénet F, Jarlier M, et al. The desmoplastic growth pattern is associated with second-stage completion and longer survival in 2-stage hepatectomy for colorectal cancer liver metastases. Surgery. 2022. PMID: 36089423. doi:10.1016/j.surg.2022.06.032
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。